SCHEMBL5502779

SCHEMBL5502779

CCC[C@]1(N)C2CC3C[C@@H](C2)CC1(C1CCCCC1)C3

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11678107 0.70 SIGMAR1 (0.33)
SCHEMBL11677852 0.67 ALDH1A1 (0.30)
Bicarbonate SCHEMBL7732730 0.66 EPHX1 (0.35)
SCHEMBL5737366 0.65
SCHEMBL5737498 0.65
SCHEMBL985887 0.65
SCHEMBL5734363 0.65
SCHEMBL5735985 0.65
SCHEMBL5249332 0.63 SIGMAR1 (0.34)
SCHEMBL15937107 0.63 GRIN2D (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765287-A2 IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMS Merz Pharma GmbH & Co. KGaA (DE) 2007-03-28 EP disclosed
WO-2006096194-A2 DRINKABLE IMMEDIATE RELEASE TABLET MADE WITH DIRECT COMPRESSION OF MEMANTINE OR NERAMEXANE MERZ PHARMA GMBH & CO. KGAA (DE) 2006-09-14 WO disclosed